Huntington's disease gene-silencing drug effective in animal studies
A single dose of an 'antisense' drug has been shown to slow, or even partially reverse, Huntington's disease in animal studies, according to a study published in Neuron....
A research study in which new ways to prevent, detect, diagnose, or treat disease are tested on human participants.
by Holly Rogers
A single dose of an 'antisense' drug has been shown to slow, or even partially reverse, Huntington's disease in animal studies, according to a study published in Neuron....
Six major UK research funding bodies have called for the continued funding of human embryonic stem cell (hESC) research in the EU's programme for research and development...
Stroke patients involved in an early stage clinical trial of a stem cell treatment in Scotland have shown signs of slight improvement....
A ten-year-old Swedish girl has become the first recipient of a donor vein treated with a patient's own stem cells...
Two drugs targeting advanced melanoma linked to a mutation in the BRAF gene are more effective than current chemotherapy at slowing the progress of the skin cancer, clinical trial results indicate...
by James Brooks
A drug that mimics broken strands of DNA and pushes treatment-resistant cancer cells to autodestruct has produced encouraging results in a first clinical trial. The medicine, DT01, is the forerunner for a new class of drug developed by researchers at the Institut Curie in Paris...
by Ana Pallesen
Two patients with corneal blindness have become the first people in the UK to have stem cells transplanted into their eyes in order to restore their sight...
A chemical produced by stem cells promotes recovery in mice with the autoimmune neurological disease, multiple sclerosis. Hepatocyte growth factor, which is produced by human mesenchymal stem cells, appeared to both repair existing damage and prevent future neurological harm in a mouse model of the disease...
by Helen Brooks
Stem cell therapy may benefit patients with chronic heart disease, according to the results of a small clinical trial carried out by US scientists....
by Ana Pallesen
An IVF test which checks whether embryos carry the correct number of chromosomes could improve the chances of a successful pregnancy, a clinical trial suggests. The test — developed by the biotech company Blue Gnome — is used five days after an egg has been fertilised and helps doctors select which embryos should be implanted during IVF treatment...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.